MRK

#40
Merck & Co., Inc.
119.75 USD
-0.39%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
119.58
119.91
Годовой диапазон
73.31
125.14
Дневное изменение
-0.39%
Месячное изменение
+3.82%
6-месячное изменение
+41.98%
Годовое изменение
+50.63%
Предыдущее закрытие
120.22
Открыть
119.58
Bid
Ask
Минимум
119.58
High
119.91
Объем
2 279
Открыть полный график

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
  • Market Capitalization 296.07 B
  • Employee 75 K
  • Founded N/A
  • CEO Robert M Davis
  • Website www.merck.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BPD168
  • Industry Technology
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Коэффициент цена/прибыль
14.46
Коэффициент цена/денежный поток
4.06
Дивиденды на акцию
3.28
Дивидендная доходность, %
3.12

Merck & Company Inc (new)

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck".

Новости